Suzanne Crowe, Director at AVITA Medical, Inc. (RCEL), bought 486 shares at $13.15 ($6K) on 2024-12-09, disclosed to the SEC on 2025-01-29.
Open-market purchase of $6k RCEL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.